Skip to Content


Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II of the Hart-Scott Rodino Antitrust Improvements Act of 1976, requires persons contemplating certain mergers or acquisitions to give the Federal Trade Commission and the Assistant Attorney General advance notice and to wait designated periods before consummation of such plans. Section 7A(b)(2) of the Act permits the agencies, in individual cases, to terminate this waiting period prior to its expiration and requires that notice of this action be published in the Federal Register.

The following transactions were granted early termination—on the dates indicated—of the waiting period provided by law and the premerger notification rules. The listing for each transaction includes the transaction number and the parties to the transaction. The grants were made by the Federal Trade Commission and the Assistant Attorney General for the Antitrust Division of the Department of Justice. Neither agency intends to take any action with respect to these proposed acquisitions during the applicable waiting period.

Early Terminations Granted December 20, 2010 Thru December 31, 2010

ET dateTrans. No.ET req statusParty name
12/20/201020110142GMcKesson Corporation; Welsh, Carson, Anderson & Stowe IX, L.P.; McKesson Corporation.
20110293GBoston Scientific Corporation; Sadra Medical, Inc.; Boston Scientific Corporation.
20110297GThe NASDAQ OMX Group, Inc.; Val E. Vaden; The NASDAO OMX Group, Inc.
20110357GOak Hill Capital Partners II, L.P.; Vantage Oncology, Inc.; Oak Hill Capital Partners II, LP.
Start Printed Page 8741
20110358GVantage Oncology, Inc.; Oak Hill Capital Partners II, L.P.; Vantage Oncology, Inc.
20110372GEbro Foods S.A.; Ricegrowers Limited; Ebro Foods S.A.
20110378GBrightpoint, Inc.; The Richard Arnesen Graham Family Descendants' Trust; Brightpoint, Inc.
20110379GAetna, Inc.; Medicity, Inc.; Aetna, Inc.
20110384GIllinois Tool Works Inc.; Royal Dutch Shell plc; Illinois Tool Works Inc.
12/21/201020110377GHelen of Troy Limited; Kaz, Inc.; Helen of Troy Limited.
12/23/201020110304GRoche Holding Ltd.; Marcadia Biotech, Inc.; Roche Holding Ltd.
12/27/201020110318GSTG III, LP; CoreLogic, Inc.; STG III, LP.
20110391GH.I.G. Bayside Debt & LBO Fund II, L.P.; Matrixx Initiatives, Inc.; H.I.G. Bayside Debt & LBO Fund II, L.P.
20110393GPrestige Brands Holdings, Inc.; Johnson & Johnson; Prestige Brands Holdings, Inc.
20110395GPBF Energy Company LLC; Sunoco, Inc.; PBF Energy Company LLC.
20110396GTPG VI DE AIV II, L.P.; Ashland Inc.; TPG VI DE AIV II, L.P.
20110398GExxon Mobil Corporation; Petrohawk Energy Corporation; Exxon Mobil Corporation.
20110399GLennox International Inc.; The Manitowoc Company, Inc.; Lennox International Inc.
20110406GCarl C. Icahn; Dynegy Inc.; Carl C. Icahn.
20110407GChina Huaneng Group; Inter Gen N.V.; China Huaneng Group.
20110408GGrupo Empresarial Kaluz, S.A. de C.V.; Rockwood Holdings, Inc.; Grupo Empresarial Kaluz, S.A. de C.V.
12/28/201020100854GKeystone Holdings, LLC; Compagnie de Saint-Gobain; Keystone Holdings, LLC.
20110394GAceto Corporation; Ronald Gold; Aceto Corporation.
12/29/201020110402GM & F Worldwide Corp.; Knowledge Universe Limited LLC; M & F Worldwide Corp.
12/30/201020110385GFairfax Financial Holdings Limited; AbitibiBowater Inc.; Fairfax Financial Holdings Limited.

For Further Information Contact: Sandra M. Peay, Contact Representative, or Renee Chapman, Contact Representative, Federal Trade Commission, Premerger Notification Office, Bureau of Competition, Room H-303, Washington, DC 20580, (202) 326-3100.

Start Signature

By direction of the Commission.

Donald S. Clark,


End Signature End Preamble

[FR Doc. 2011-3174 Filed 2-14-11; 8:45 am]